Pharmacotherapy, immunosuppressive, whole body

Legacy Content

Explanation: This is a legacy procedure, its stop date is in the past.
Successor: No successor was entered

Click Expand to show legacy content.

CCI Picklist
Procedure:	Pharmacotherapy, immunosuppressive, whole body
CCI Picklist code:	1.ZZ.35.HA-M8
CCI Collection Mode:	CCI collect each
Start Date:	2018-10-10
Stop Date:

This procedure is a part of CCI Collection via CCI Picklist.

Additional Info

Includes:

Chemotherapy for cancer
use of chemo drugs for other conditions, such as MS

Template:Discussion This could potentially be a long list.

See https://en.wikipedia.org/wiki/Immunosuppressive_drug

Should more info/guidelines be included as to which drugs qualify for collection with this CCI picklist code?

Depending on the drug list, there could be implications for counting.

Alternate CCIs to consider coding instead or in addition

Other procedure in Pharmacotherapy:

	Has CCI Picklist Code	Has CCI 1 Code	Has CCI 2 Code
CAR-T (Chimeric Antigen Receptor T-cell Immunotherapy)	XW043C3
Pharmacotherapy, thrombolytic agent			35.HA-1C

Other procedure in Therapeutic Procedure:

Related ICD10 Codes

Neoplastic codes:
Acute erythroblastic leukemia (erythroleukemia) Acute lymphoblastic leukemia (ALL) Acute megakaryoblastic leukemia Acute myeloid leukemia (AML) Acute myelomonocytic leukaemia (AMML) Acute promyelocytic leukaemia (APL) Adrenal gland, benign neoplasm Adrenal gland, metastatic malignancy to it (also code primary site) Adrenal gland, primary malignancy Antineoplastic/chemotherapy or immunosuppressive drugs, adverse effect Antineoplastic/chemotherapy or immunosuppressive drugs, overdose/toxicity Benign neoplasm, NOS Biliary tract, primary malignancy Bladder, primary malignancy Bone NOS, pathologic fracture due to neoplastic disease Bone or bone marrow, metastatic malignancy to it (also code primary site) Bone or cartilage (any location), primary malignancy Bone or cartilage, benign neoplasm Brain or meninges, metastatic malignancy to it (also code primary site) Brain, primary malignancy Breast, benign neoplasm Breast, primary malignancy Carcinoid syndrome Carcinoma in situ, any site Central nervous system NOS, benign neoplasm Central nervous system NOS, primary malignancy Cervix, dysplasia Cervix, primary malignancy Chronic lymphocytic leukemia (CLL) Chronic myeloid leukemia (CML) Colon (large intestine) or rectum or anus, benign neoplasm Colon (large intestine), primary malignancy Connective or soft tissue NOS (external or internal), primary malignancy Digestive system NOS, benign neoplasm Disorder of anus or rectum, NOS Endocrine gland NOS, benign neoplasm Endocrine gland NOS, primary malignancy Esophagus, benign neoplasm Esophagus, primary malignancy Essential thrombocythemia/thrombocytosis Eye or related structures, benign neoplasm Eye, primary malignancy Fat, benign neoplasm Female genitalia NOS (internal or external), primary malignancy Female genitals, benign neoplasm Femur or pelvis, pathologic fracture due to neoplastic disease GI organ NOS, primary malignancy Gallbladder, primary malignancy Gastrointestinal system NOS, metastatic malignancy to it (also code primary site) Genetic susceptibility to malignant neoplasm Hairy cell leukemia Head and neck and face, primary malignancy Heart, benign neoplasm Heart, primary malignancy Hemangioma or lymphangioma, benign neoplasm, any site Hodgkin's lymphoma (Hodgkin's disease) Hypercalcemia Intrathoracic structures NOS, benign neoplasm Kaposi's sarcoma Kidney or ureter or bladder or urethra, benign neoplasm Kidney, primary malignancy Larynx, benign neoplasm Larynx, primary malignancy Leukemia, NOS Lip or mouth or tonsils or pharynx, primary malignancy Liver or biliary system, benign neoplasm Liver or biliary system, metastatic malignancy to it (also code primary site) Liver, primary malignancy Lung and/or bronchus, primary malignancy Lung or bronchi, benign neoplasm Lung, metastatic malignancy to it (also code primary site) Lymph nodes, benign neoplasm Lymph nodes, metastatic malignancy to them (also code primary site) Lymphoid leukemia, NOS Lymphoma, NOS Male genitalia NOS (internal or external), primary malignancy Male genitals, benign neoplasm Malignancy (clonal disorder) of blood or lymphoid tissue, NOS Malignant carcinoid tumor Malignant immunoproliferative disease Mediastinum, primary malignancy Meninges, benign neoplasm Meninges, primary malignancy Mesothelioma (any site) Monoclonal gammopathy of undetermined significance (MGUS) Monocytic leukemia, acute or chronic Mouth or pharynx or salivary glands, benign neoplasm Multiple endocrine adenomatosis (multiple endocrine neoplasia syndrome, MEN) Multiple myeloma Myelodysplastic syndrome/myelodysplasia (preleukemia, refractory anemia) Myeloproliferative diseases Nasal cavity or sinus or middle ear, primary malignancy Neoplasm of uncertain behavior (i.e. not clear if benign or malignant), NOS Nerves, peripheral or autonomic, primary malignancy Nerves, peripheral, benign neoplasm Non-Hodgkin's lymphoma Ovary, benign neoplasm Ovary, primary malignancy Pancreas, benign neoplasm Pancreas, primary malignancy ... further results

Imaging Px	Diagnostic Px	Therapeutic Px	Reproductive Px Obstetric Px	Musculoskeletal/soft tissue Px Abdomen Arm Back Bone/joint Ear Leg Organ Soft tissue Thorax
Neuro Px	Respiratory Px Thorax	Cardiovascular Px Angiogram Cardiac Lymphatic system Vessel	Gastrointestinal Px	Genitourinary Px	‎Misc Px Administrative Px Ear Organ Pharmacotherapy Transfusion
CCI_Picklist		CCI component 1 codes - what organ was something done to		CCI component 2 codes - what was done

Pharmacotherapy, immunosuppressive, whole body

Legacy Content

Contents

Additional Info

Alternate CCIs to consider coding instead or in addition

Related ICD10 Codes

Related Articles